Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal Mapping of Radiation-Induced Neural Injury and Mitigation in Human Cortical Organoids.

bioRxiv : the preprint server for biology·2026
Same author

Critical role of cell competition in gliomagenesis.

bioRxiv : the preprint server for biology·2026
Same author

Publisher Correction: Valproic acid targets IDH1 mutants through alteration of lipid metabolism.

npj metabolic health and disease..·2025
Same author

EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis.

The Journal of clinical investigation·2025
Same author

Non-muscle myosin II inhibition at the site of axon injury increases axon regeneration.

Nature communications·2025
Same author

Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells.

Acta neuropathologica communications·2025

Related Experiment Video

Updated: Jul 8, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

BMPing off glioma stem cells.

Ichiro Nakano1, Kuniyasu Saigusa, Harley I Kornblum

  • 1Department of Neurological Surgery, University of California, Los Angeles, School of Medicine, Los Angeles, CA 90095, USA.

Cancer Cell
|January 3, 2008
PubMed
Summary
This summary is machine-generated.

Bone morphogenetic proteins (BMPs) affect brain tumor stem cells (BTSC) differently, either promoting or inhibiting differentiation. This occurs due to epigenetic silencing of BMP receptor 1B (BMPR1B) in some BTSC lines.

More Related Videos

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

Related Experiment Videos

Last Updated: Jul 8, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

Area of Science:

  • Neuro-oncology
  • Stem Cell Biology
  • Epigenetics

Background:

  • Brain tumor stem cells (BTSC) share similarities with neural stem cells (NSC).
  • Bone morphogenetic proteins (BMPs) exhibit differential effects on NSC proliferation and differentiation based on developmental stage.
  • Understanding BMP signaling in BTSC is crucial for developing targeted therapies.

Discussion:

  • BMPs demonstrate varied impacts on astrocytic differentiation in different BTSC lines.
  • Epigenetic silencing of BMP receptor 1B (BMPR1B) underlies BMP-induced inhibition of differentiation in specific BTSC populations.
  • This highlights the critical role of the BMP signaling pathway in regulating BTSC behavior.

Key Insights:

  • BMP signaling pathway critically influences brain tumor stem cell differentiation.
  • Heterogeneity among BTSC lines affects their response to BMPs.
  • Epigenetic mechanisms, specifically BMPR1B silencing, mediate differential BMP responses.

Outlook:

  • Investigating BMP signaling and epigenetic modifications in BTSC is essential for therapeutic strategies.
  • Targeting BMP pathways may offer novel approaches for brain tumor treatment.
  • Accounting for BTSC heterogeneity is vital for effective therapeutic development.